Astrazeneca
Pharma
Data as of 4 Oct 2026
Markdown version
Markdown version
Astrazeneca was mentioned 78 times in 15 outlets across 5 countries over the last 12 months. 22% of that coverage was positive and 3% negative. 94% was editorial rather than PR or paid placement.
MENTIONS · 12M
78
84 all-time
OUTLETS · 12M
15
in 5 countries
AVG SENTIMENT
+0.153
EDITORIAL
94%
5 PR · 73 editorial
Recent coverage
AstraZeneca new partner to WIN WIN Award - Cision News
news.cision.com · INT · 31 Aug 2026 · positive
Weekly Recap: Pipeline setbacks and Phase 3 TROPION-Urothelial04 launch - TradingView
tradingview.com · INT · 31 Aug 2026 · negative
What Is AstraZeneca (LSE:AZN) Signaling With Its Latest Late Stage Trial Results? - Yahoo Finance
finance.yahoo.com · INT · 28 Aug 2026 · positive
AstraZeneca, Amgen notch another late-stage win for Tezspire, this time in esophagitis - BioSpace
biospace.com · INT · 27 Aug 2026 · positive
AstraZeneca growth spurs regional workforce push in Central Virginia - WVIR
29news.com · INT · 27 Aug 2026 · positive
AstraZeneca (AZN) Tezspire improves swallowing symptoms in Phase III trial - Stock Titan
stocktitan.net · INT · 27 Aug 2026 · positive
Daiichi Sankyo and AstraZeneca’s Datroway Enters Phase 3 Adjuvant Trial in High-Risk Muscle-Invasive Urothelial Cancer - Oncodaily
oncodaily.com · INT · 26 Aug 2026 · positive
Executives from Lloyds, AstraZeneca and Shell will join ISG’s London AI summit - Stock Titan
stocktitan.net · GB · 18 Aug 2026 · positive
Coverage over time · mentions per month
Mentions per month as a table
| Month | Mentions |
|---|---|
| 2025-11 | 0 |
| 2025-12 | 1 |
| 2026-01 | 3 |
| 2026-02 | 2 |
| 2026-03 | 0 |
| 2026-04 | 2 |
| 2026-05 | 12 |
| 2026-06 | 43 |
| 2026-07 | 1 |
| 2026-08 | 13 |
| 2026-09 | 0 |
| 2026-10 | 0 |
Share of voice among Pharma peers · 12m
| Brand | Mentions | Share |
|---|---|---|
| Eli lilly | 130 | 23% |
| Astrazeneca | 78 | 14% |
| Pfizer | 64 | 11% |
| Johnson & johnson | 59 | 10% |
| Novo nordisk | 46 | 8% |
| Merck | 44 | 8% |
| Sandoz | 41 | 7% |
| Moderna | 38 | 7% |
| Bayer | 36 | 6% |
| Roche | 36 | 6% |
Track Astrazeneca against its rivals
Daily mentions, sentiment, share of voice and alerts — only what is actually about the brand.
Start trackingIs this your brand?
Claim the page to correct aliases, website or sector, and see the full picture.
Claim this page